2014
DOI: 10.1074/jbc.m114.589630
|View full text |Cite
|
Sign up to set email alerts
|

A Liquid Chromatography-Mass Spectrometry-based Approach to Characterize the Substrate Specificity of Mammalian Heparanase

Abstract: Background: Heparanase remodels ECM and is associated with cancer metastasis and angiogenesis. Results: An LC-MS-based approach was developed to profile the structures of the heparanase cleavage sites in heterogeneous HS chains. Conclusion: Heparanase cleaves at the non-reducing side of highly sulfated HS domains. Significance: The results suggest a mechanism for heparanase to activate nascent growth factor binding domains within HS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
32
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(33 citation statements)
references
References 46 publications
1
32
0
Order By: Relevance
“…4B), confirming that the staining is indeed on HS. On the other hand, HPSE digestion on HS results in uniform N-sulfated GlcNAc residue (GlcNS) at the ends of HS chains (Mao, Y., Huang, Y., et al 2014). As a result, pretreatment with HPSE significantly increased the labeling (Fig.…”
Section: Strict Specificity Of Hs Stainingmentioning
confidence: 99%
See 1 more Smart Citation
“…4B), confirming that the staining is indeed on HS. On the other hand, HPSE digestion on HS results in uniform N-sulfated GlcNAc residue (GlcNS) at the ends of HS chains (Mao, Y., Huang, Y., et al 2014). As a result, pretreatment with HPSE significantly increased the labeling (Fig.…”
Section: Strict Specificity Of Hs Stainingmentioning
confidence: 99%
“…HS is synthesized by exostosins (EXTs), dual enzymes that have both GlcA and GlcNAc transferase activities (Senay, C., Lind, T., et al 2000). HS is degraded by heparanase (HPSE), an endoglucuronidase that specifically hydrolyzes the βGlcA-1,4-GlcNAc bond in highly sulfated HS domains (Mao, Y., Huang, Y., et al 2014, Vlodavsky, I., Friedmann, Y., et al 1999. HS can also be digested with bacterial lyases such as heparinase III, which leaves an unsaturated GlcA residue (ΔGlcA) at its non-reducing end (Hovingh, P. and Linker, A.…”
Section: Introductionmentioning
confidence: 99%
“…Because heparanase is strongly implicated in the breakdown of matrix in tumor metastasis, these modified heparin compounds have potential as antimetastatic agents (Casu et al, 2008). The detailed substrate specificity of heparanase was studied recently (Mao et al, 2014) using a mass spectrometric approach. Heparanase was found to cleave at the nonreducing side of highly sulfated domains, exposing potential FGF-2 binding motifs and thereby increasing the FGF-2 potentiating capacity of treated HS.…”
Section: G Interactions Between Heparin and Pathogensmentioning
confidence: 99%
“…The challenge in the development of structurally defined heparanase probes with fluorescence readout largely stems from its elusive substrate recognition mode, despite the extensive investigations being made [23][24][25] . One known fact is that heparanase is an endoglycosidase that can cleave the internal glycosidic bond between a glucuronic acid (GlcUA) residue and an Nsulfoglucosamine (GlcN(NS)) residue bearing either a 3-O-sulfo or a 6-O-sulfo group 26 .…”
Section: Structurally Defined Fluorogenic Heparanase Probesmentioning
confidence: 99%